Announcements

Announcements

Paul G. Allen Frontiers Group [to 8 Jun 2019]
https://alleninstitute.org/what-we-do/frontiers-group/news-press/
No new digest content identified.

BMGF – Gates Foundation [to 8 Jun 2019]
http://www.gatesfoundation.org/Media-Center/Press-Releases
No new digest content identified.

Bill & Melinda Gates Medical Research Institute [to 8 Jun 2019]
https://www.gatesmri.org/
The Bill & Melinda Gates Medical Research Institute is a non-profit biotech organization. Our mission is to develop products to fight malaria, tuberculosis, and diarrheal diseases—three major causes of mortality, poverty, and inequality in developing countries. The world has unprecedented scientific tools at its disposal; now is the time to use them to save the lives of the world’s poorest people
No new digest content identified.

CARB-X [to 8 Jun 2019]
https://carb-x.org/
CARB-X is a non-profit public-private partnership dedicated to accelerating antibacterial research to tackle the global rising threat of drug-resistant bacteria.
No new digest content identified.

CEPI – Coalition for Epidemic Preparedness Innovations [to 8 Jun 2019]
http://cepi.net/
04 Jun 2019
The world needs a Chikungunya vaccine
By Richard Hatchett
Over a billion people live in areas where Chikungunya is endemic. We urgently need a vaccine against this disease.

04 Jun 2019
CEPI awards up to US$21 million to Themis Bioscience for Phase 3 Chikungunya Vaccine Development
Vienna, Austria, and Oslo, Norway, June 4, 2019—Themis Bioscience and the Coalition for Epidemic Preparedness Innovations (CEPI) announced a second partnering agreement under which CEPI, with support from the European Union’s (EU’s) Horizon 2020 programme, will provide up to US$21 million of non-dilutive capital* for Themis’ Phase 3-ready Chikungunya vaccine (MV-CHIK). The funding will underwrite a collaborative effort to accelerate regulatory approval of Themis’ Chikungunya vaccine and ensure that at-risk populations have access to the vaccine. The agreement will provide a significant portion of the capital required for Themis’ Phase 3 clinical trial. Clinical trial applications will be submitted to regulatory authorities in the second half of 2019, with the trial initiation expected shortly thereafter. The pivotal multi-center Phase 3 trial will be launched in Europe, US and the Americas and will also test a single-shot regimen…

Clinton Health Access Initiative, Inc. (CHAI) [to 8 Jun 2019]
https://clintonhealthaccess.org/about/
No new digest content identified.

EDCTP [to 8 Jun 2019]
http://www.edctp.org/
The European & Developing Countries Clinical Trials Partnership (EDCTP) aims to accelerate the development of new or improved drugs, vaccines, microbicides and diagnostics against HIV/AIDS, tuberculosis and malaria as well as other poverty-related and neglected infectious diseases in sub-Saharan Africa, with a focus on phase II and III clinical trials
No new digest content identified.

Emory Vaccine Center [to 8 Jun 2019]
http://www.vaccines.emory.edu/
No new digest content identified.

European Medicines Agency [to 8 Jun 2019]
http://www.ema.europa.eu/ema/
News and press releases
No new digest content identified.

European Vaccine Initiative [to 8 Jun 2019]
http://www.euvaccine.eu/news-events
No new digest content identified.

FDA [to 8 Jun 2019]
https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/default.htm
No new digest content identified.

Fondation Merieux [to 8 Jun 2019]
http://www.fondation-merieux.org/
Christophe Mérieux Prize
Maryline Bonnet receives the 2019 Christophe Mérieux Prize for her research on tuberculosis in developing countries
June 6, 2019, Paris (France)
The 2019 Christophe Mérieux Prize was awarded by Fondation Christophe et Rodolphe Mérieux of the Institut de France to Maryline Bonnet on Wednesday June 5th under the dome of the Institut de France. The pulmonologist and research director in Uganda was awarded for her tuberculosis research program in developing countries.

Gavi [to 8 Jun 2019]
https://www.gavi.org/
06 June 2019
Gavi, NEC, and Simprints to deploy world’s first scalable child fingerprint identification solution to boost immunisation in developing countries
Gavi, the Vaccine Alliance, NEC Corporation, and Simprints Technology Ltd. have signed a memorandum of understanding on the use of biometrics to improve immunisation coverage in developing countries.
Despite enormous progress over the past two decades, there are still approximately 20 million children who do not receive a basic course of vaccines worldwide, leaving them exposed to some of the world’s deadliest diseases.

One key cause is the fact that only half of all children under 5 in sub-Saharan Africa are currently registered at birth, leaving many without an official identity. This makes it difficult for health practitioners to ensure these infants get the vaccines they need at the right time.
Guided by Gavi’s experience and expertise in immunisation, this new project will combine Simprints’ biometric fingerprint technology and NEC’s reinforced authentication engine to help create digital identities for children 1-5 years of age and boost immunisation coverage in developing countries.

This new partnership will deploy the world’s first scalable fingerprint identification solution to give children aged 1-5 a digital ID linked to an accurate, complete medical record. All biometric records will be stored securely by Simprints, a UK-based non-profit social enterprise, after caregivers give informed consent to having their children’s biometric data taken…

GHIT Fund [to 8 Jun 2019]
https://www.ghitfund.org/newsroom/press
GHIT was set up in 2012 with the aim of developing new tools to tackle infectious diseases that devastate the world’s poorest people. Other funders include six Japanese pharmaceutical
No new digest content identified.

Global Fund [to 8 Jun 2019]
https://www.theglobalfund.org/en/news/
Feature Story
Global Fund Data Explorer
05 June 2019
Visualize Global Fund Investments and Results through the new Data Explorer

News
Takeda Makes First Private Sector Pledge for Global Fund Replenishment
03 June 2019
OSAKA/GENEVA – Takeda Pharmaceutical Company Limited today became the first private sector company to announce a financial commitment to the Global Fund’s Sixth Replenishment. The new pledge, consisting of JP ¥ 1 billion (approximately US$9 million) over five years, builds on Takeda’s previous contribution to the Global Fund…

Hilleman Laboratories [to 8 Jun 2019]
http://www.hillemanlabs.org/
No new digest content identified.

Human Vaccines Project [to 8 Jun 2019]
http://www.humanvaccinesproject.org/media/press-releases/
No new digest content identified.

IAVI [to 8 Jun 2019]
https://www.iavi.org/newsroom
No new digest content identified.

 

IFFIm
http://www.iffim.org/library/news/press-releases/
No new digest content identified.

IFRC [to 8 Jun 2019]
http://media.ifrc.org/ifrc/news/press-releases/
Selected Press Releases, Announcements
Italy
Global youth gathering of thousands to celebrate 100 years of world’s largest humanitarian network
Geneva/Rome, 6 June 2019 – More than 10,000 young Red Cross and Red Crescent leaders and volunteers from 140 countries will gather in northern Italy from 17-23 June to celebrate the centenary of the International Federation of Red Cross and Red Crescen …

IVAC [to 8 Jun 2019]
https://www.jhsph.edu/research/centers-and-institutes/ivac/index.html
No new digest content identified.

IVI [to 8 Jun 2019]
http://www.ivi.int/
IVI News & Announcements
No new digest content identified.

JEE Alliance [to 8 Jun 2019]
https://www.jeealliance.org/
Selected News and Events
No new digest content identified.

MSF/Médecins Sans Frontières [to 8 Jun 2019]
http://www.msf.org/
Selected News; Project Updates, Reports
El Salvador
Behind the wheel – driving ambulances in El Salvador’s red zones
Voices from the Field 7 Jun 2019

Pakistan
Witnessing poor mother and child healthcare in Balochistan
Project Update 6 Jun 2019

Iran
Providing health care to vulnerable people in Lorestan after floods i…
Project Update 6 Jun 2019

Yemen
Endemic in Yemen, cholera still hits Yemenis hard
Project Update 5 Jun 2019

NIH [to 8 Jun 2019]
http://www.nih.gov/news-events/news-releases
June 6, 2019
NIH HIV experts prioritize research to achieve sustained ART-free HIV remission
— Scientists explain vision for the future of ART in JAMA commentary.

Immune cells play unexpected role in early tuberculosis infection
June 5, 2019 — NIH-supported discovery may provide a new target for TB drugs, vaccines.

NIH-supported study reveals a novel indicator of influenza immunity
June 3, 2019 — Findings could help scientists design more effective influenza vaccines and lead to the development of novel universal influenza vaccines.

PATH [to 8 Jun 2019]
https://www.path.org/media-center/
June 3, 2019 by PATH
PATH and Sinapi Biomedical launch lifesaving medical device to combat postpartum hemorrhage
Ellavi—the first commercially available, low-cost, fully assembled uterine balloon tamponade—receives internationally-recognized CE marking

Sabin Vaccine Institute [to 8 Jun 2019]
http://www.sabin.org/updates/pressreleases
No new digest content identified.

UNAIDS [to 8 Jun 2019]
http://www.unaids.org/en
Selected Press Releases/Reports/Statements
5 June 2019
Malawi: remember where we have come from to move forward

5 June 2019
Young women demand accountability at Women Deliver

4 June 2019
Chisinau signs the Paris Declaration
Ruslan Codrenu, the Acting Mayor of Chisinau, Republic of Moldova, signed the Paris Declaration to end the AIDS epidemic in cities on 31 May. He committed the city to achieving the 90–90–90 targets by 2020, whereby 90% of all people living with HIV know their HIV status, 90% of people who know their HIV-positive status are on treatment and 90% of people on treatment have suppressed viral loads. The city will specifically focus on marginalized and vulnerable people and on ending stigma and discrimination.’’…

3 June 2019
Changing the lives of transgender people in Malawi

3 June 2019
TB-related deaths among people living with HIV falling, but not by enough
Even though tuberculosis (TB) is preventable and curable, it is the top infectious killer worldwide, claiming around 4400 lives a day. TB also remains the leading cause of death among people living with HIV, causing one in three AIDS-related deaths. However, progress has been made―TB-related deaths among people living with HIV peaked in 2005, at 600 000 deaths; since then, they have halved, to 300 000 in 2017…

UNICEF [to 8 Jun 2019]
https://www.unicef.org/media/press-releases
Selected Statements, Press Releases, Reports
Press release
UNICEF ramps up humanitarian assistance to children in Venezuela, delivers 55 tons of health supplies since January
3.2 million children – or 1 in 3 – need assistance
07/06/2019

Press release
Pocket-sized innovation, giant impact: New app and online system launches in South Sudan to support most vulnerable children
The innovations will support case workers helping unaccompanied and separated children, child survivors of sexual violence, and children associated with armed groups.
06/06/2019

Press release
115 million boys and men around the world married as children – UNICEF
First ever analysis on child grooms brings global child marriage figures to 765 million
06/06/2019

Press release
New Dove and UNICEF partnership to reach 10 million young people with essential self-esteem and body confidence education
05/06/2019

Press release
Only 6 per cent of children in Africa live in areas where air pollution is reliably measured at the ground-level
More reliable ground-level measurements are required to combat this silent killer of children, particularly in Africa where the problem is growing and gravely under-studied
04/06/2019

Press release
World not delivering quality maternal health care to poorest mothers – UNICEF
Millions of mothers at risk due to prohibitive health care costs, lack of access to services and skilled professionals, and child marriage
03/06/2019

Vaccine Confidence Project [to 8 Jun 2019]
http://www.vaccineconfidence.org/
No new digest content identified.

Vaccine Education Center – Children’s Hospital of Philadelphia [to 8 Jun 2019]
http://www.chop.edu/centers-programs/vaccine-education-center
No new digest content identified.

Wellcome Trust [to 8 Jun 2019]
https://wellcome.ac.uk/news
Opinion | 6 June 2019
New funding model to replace the Public Engagement Fund
Imran Khan, Greer Roberts, Public Engagement team – Wellcome
This autumn we’ll be announcing new partnerships that will allocate funding to innovative public engagement projects. To allow us to do so, we’re closing the Public Engagement Fund.

The Wistar Institute [to 8 Jun 2019]
https://www.wistar.org/news/press-releases
Press Release Jun. 3, 2019
University Place Associates and The Wistar Institute Collaborate to Create New Research and Discovery Hub in Philadelphia’s University City District
Allows for establishment of collaborations among Wistar and academic research and biotechnology start-up communities in the region.

World Organisation for Animal Health (OIE) [to 8 Jun 2019]
http://www.oie.int/en/for-the-media/press-releases/2019/
No new digest content identified.

 

::::::

BIO [to 8 Jun 2019]
https://www.bio.org/insights/press-release
Jun 5 2019
BIO Applauds House Passage of the Pandemic and All-Hazards Preparedness and Advancing Innovation Act
The Biotechnology Innovation Organization (BIO) applauds members of the House of Representatives for passing the Pandemic and All-Hazards Preparedness and Advancing Innovation Act (PAHPAI) of 2019.

DCVMN – Developing Country Vaccine Manufacturers Network [to 8 Jun 2019]
http://www.dcvmn.org/
No new digest content identified.

IFPMA [to 8 Jun 2019]
http://www.ifpma.org/resources/news-releases/
No new digest content identified.

PhRMA [to 8 Jun 2019]
http://www.phrma.org/press-room
No new digest content identified.